These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27511732)

  • 21. Crystal structure of the giant panda MHC class I complex: First insights into the viral peptide presentation profile in the bear family.
    Yuan H; Ma L; Zhang L; Li X; Xia C
    Protein Sci; 2020 Dec; 29(12):2468-2481. PubMed ID: 33078460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.
    Zeng L; Sullivan LC; Vivian JP; Walpole NG; Harpur CM; Rossjohn J; Clements CS; Brooks AG
    J Immunol; 2012 Jan; 188(1):302-10. PubMed ID: 22131332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural principles that govern the peptide-binding motifs of class I MHC molecules.
    Zhang C; Anderson A; DeLisi C
    J Mol Biol; 1998 Sep; 281(5):929-47. PubMed ID: 9719645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MHC class I-peptide interactions and TCR recognition.
    Young AC; Zhang W; Sacchettini JC; Nathenson SG
    Cancer Surv; 1995; 22():17-36. PubMed ID: 7536627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and Peptidome of the Bat MHC Class I Molecule Reveal a Novel Mechanism Leading to High-Affinity Peptide Binding.
    Qu Z; Li Z; Ma L; Wei X; Zhang L; Liang R; Meng G; Zhang N; Xia C
    J Immunol; 2019 Jun; 202(12):3493-3506. PubMed ID: 31076531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rigidification of the alpha2 helix of an MHC class I molecule by a valine to proline mutation in position 165 does not prevent peptide-specific antigen presentation.
    Plaksin D; Polakova K; Mage MG; Margulies DH
    J Immunol; 1997 Nov; 159(9):4408-14. PubMed ID: 9379039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncanonical peptides in complex with MHC class I.
    Apostolopoulos V; Lazoura E
    Expert Rev Vaccines; 2004 Apr; 3(2):151-62. PubMed ID: 15056041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural analysis of MHC class I molecules with bound peptide antigens.
    Wilson IA; Fremont DH
    Semin Immunol; 1993 Apr; 5(2):75-80. PubMed ID: 8504218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding.
    Chappell P; Meziane el K; Harrison M; Magiera Ł; Hermann C; Mears L; Wrobel AG; Durant C; Nielsen LL; Buus S; Ternette N; Mwangi W; Butter C; Nair V; Ahyee T; Duggleby R; Madrigal A; Roversi P; Lea SM; Kaufman J
    Elife; 2015 Apr; 4():e05345. PubMed ID: 25860507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
    Hulpke S; Baldauf C; Tampé R
    FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen presentation by non-classical class I molecules.
    Stroynowski I; Lindahl KF
    Curr Opin Immunol; 1994 Feb; 6(1):38-44. PubMed ID: 8172679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide-independent stabilization of MHC class I molecules breaches cellular quality control.
    Hein Z; Uchtenhagen H; Abualrous ET; Saini SK; Janßen L; Van Hateren A; Wiek C; Hanenberg H; Momburg F; Achour A; Elliott T; Springer S; Boulanger D
    J Cell Sci; 2014 Jul; 127(Pt 13):2885-97. PubMed ID: 24806963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity.
    Harndahl M; Rasmussen M; Roder G; Dalgaard Pedersen I; Sørensen M; Nielsen M; Buus S
    Eur J Immunol; 2012 Jun; 42(6):1405-16. PubMed ID: 22678897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nα-terminal acetylation for T cell recognition: molecular basis of MHC class I-restricted nα-acetylpeptide presentation.
    Sun M; Liu J; Qi J; Tefsen B; Shi Y; Yan J; Gao GF
    J Immunol; 2014 Jun; 192(12):5509-19. PubMed ID: 24829406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tapasin enhances MHC class I peptide presentation according to peptide half-life.
    Howarth M; Williams A; Tolstrup AB; Elliott T
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11737-42. PubMed ID: 15286279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide-major histocompatibility complex class I complex: from the structural and molecular basis to pharmacological principles and therapeutic applications.
    Hudrisier D; Gairin JE
    Curr Top Microbiol Immunol; 1998; 232():75-97. PubMed ID: 9557394
    [No Abstract]   [Full Text] [Related]  

  • 39. Peptide binding by class I and class II MHC molecules.
    Batalia MA; Collins EJ
    Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.
    Theodossis A; Guillonneau C; Welland A; Ely LK; Clements CS; Williamson NA; Webb AI; Wilce JA; Mulder RJ; Dunstone MA; Doherty PC; McCluskey J; Purcell AW; Turner SJ; Rossjohn J
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5534-9. PubMed ID: 20212169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.